
Regulatory facilitation for global markets.
Assisting pharmaceutical companies in LMICs with the submission of drug dossiers to highly regulated agencies such as MHRA and EMA, leveraging Marketing Authorisation to expedite approval processes.
Our Services
At Targeted Solutions AG, we offer a comprehensive suite of services designed to support pharmaceutical companies in Low and Middle-Income Countries (LMICs).
Through strategic partnerships and close collaboration with our clients, we help improve the accessibility and affordability of essential medications worldwide.

Expertise
Our expertise combines regulatory navigation, global market insight, and practical solutions tailored to diverse regional requirements.
Access
Dossier submission, regulatory navigation, market-entry planning, and execution support for pharmaceutical companies operating in LMICs.

Assisting pharmaceutical companies in LMICs with the submission of drug dossiers to highly regulated agencies such as MHRA and EMA, leveraging Marketing Authorisation to expedite approval processes.

Offering expert advice on navigating the complex regulatory landscape, ensuring compliance, and achieving successful drug approvals in various jurisdictions.

Generating detailed reports and assessments to support drug approval submissions and to advise on regulatory strategies for entering new markets.

Coordinating and managing projects to enhance drug availability in LMICs, from conception to regulatory approval and market launch.

Providing statistical data analysis, modeling, and simulation services to support pharmaceutical product development, approval, and market positioning.

Offering workshops, training sessions, and continuing education programs tailored to the pharmaceutical industry's needs, focusing on regulatory compliance and market access.
Transfer
Scientific, clinical, and strategic support that helps pharmaceutical technologies move from development into accessible market delivery.

Providing support and advisory services to facilitate the transfer of pharmaceutical technologies and innovations to market, especially in LMICs.

Conducting and supporting research initiatives focused on repurposing small molecules and developing accessible drug formulations for LMICs.

Assisting in the formulation and implementation of innovative strategies to overcome barriers to medication access, with a focus on sustainability and impact.
Partnership
Communication, knowledge exchange, and network-building across companies, regulators, and health organizations.

Advising and assisting with the publication of scientific research and developing communication strategies to engage stakeholders and promote public health initiatives.

Building and maintaining a network among pharmaceutical companies, regulatory agencies, and health organizations to facilitate knowledge exchange and collaboration to improve global health outcomes.
Engagement
We structure each engagement around the scope, duration, and complexity of the work. Flexible arrangements support efficient planning and cost-effective collaboration.
Scope
Each service is discussed individually to understand the specific project context, challenges, timelines, and requirements.
Pricing
Engagements may be structured around hourly, daily, weekly, monthly, or project-specific arrangements depending on the work involved.
Continuity
For broader or more complex initiatives, custom arrangements can support continuity, planning confidence, and cost-effective delivery.